Purdue Institute for Drug Discovery

PTPN22 inhibitors

Overview: 

Inhibitors of PTPN22 for cancer immunotherapy.

Status: 

Purdue Faculty: 

Dr. Zhong-Yin Zhang

Research Articles: 

Systemic inhibition of PTPN22 augments anticancer immunity